Related Experiment Video
Updated: Jul 23, 2026
07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Radioisotopic pulmonary lobectomy: feasibility study in dogs
J G Llaurado1, L A Brewer, D A Elam
1Nuclear Medicine Service, Veterans Hospital, Loma Linda, CA 92357.
Summary
Researchers explored radioactive microspheres as a lung cancer treatment. Phosphorus-32 labeled microspheres effectively destroyed targeted lung lobes in dogs, sparing healthy tissue, suggesting potential for "radioisotopic pulmonary lobectomy".
Area of Science:
- Oncology
- Radiology
- Veterinary Medicine
Background:
- Lung cancer treatment options are limited, especially for inoperable cases.
- There is a need for localized treatments that minimize systemic toxicity.
Purpose of the Study:
- To investigate the efficacy of phosphorus-32 (32P) labeled microspheres for targeted destruction of lung lobes.
- To evaluate the safety and localized effects of this treatment in a canine model.
Main Methods:
- 12 dogs received injections of 740 MBq of 32P-labeled microspheres into a selected pulmonary artery lobe.
- 6 control dogs received unlabeled microspheres.
- Organs were harvested from 1 week to 12 months post-injection for gross and histological examination.
Main Results:
- 32P-treated lobes showed progressive necrosis and contraction, becoming scarred remnants by 12 months.
- Over 94% of the 32P dose remained in the injected lobe, with minimal systemic distribution (<0.1% in major organs).
- Control lobes exhibited only minimal inflammatory changes.
Conclusions:
- Targeted delivery of 32P-labeled microspheres can achieve high radiation doses (approx. 1,500 Gy) to a specific lung lobe.
- This method shows potential for a localized
- radioisotopic pulmonary lobectomy
- with minimal damage to surrounding tissues and organs.
